1. ACCELERATING CLINICAL AND TRANSLATIONAL RESEARCH www.indianactsi.org CTSI Funding Opportunities https://www.indianactsi.org/grantinfo

2. ACCELERATING CLINICAL AND TRANSLATIONAL RESEARCH www.indianactsi.org Grant Application Process

3. ACCELERATING CLINICAL AND TRANSLATIONAL RESEARCH www.indianactsi.org CTR Grants (Collaborative Translational Research) Summary: This award is to foster collaborations between investigators at IUB, Purdue, ND, IUSM, and IUPUI in translational research projects with strong potential to develop into externally funded programs or IP. Award amount: $75,000 max. (split between collaborators) Project period: 1-year (+ 1-year NCE) Qualifications: Projects must have participation by two (or more) principal investigators representing at least two CTSI partner institutions Schedule for award: RFA – March  Applications Due ~ May  Awards Announced August

4. ACCELERATING CLINICAL AND TRANSLATIONAL RESEARCH www.indianactsi.org Project Development Teams Summary: Provides grant writing mentoring, IRB and IP advice, identifies partners. Can also provide funding to support development of preliminary data for external grant submissions. Award amount: $10,000 max. Project period: 1-year (+ 1-year NCE) Qualifications: Translational research, external funding strategy, PU-PDT (predominantly preclinical research) can partner with other PDTs to meet expertise requirements. Schedule for award: Rolling application process, no set deadline.

5. ACCELERATING CLINICAL AND TRANSLATIONAL RESEARCH www.indianactsi.org Core Pilot Funding (CTSI-designated Core facilities) Summary: Promotes use of CTSI cores across CTSI partner institutions and supports science with a high potential for external funding or IP. Funds are used as an expense account at the Core facility. No other expenses qualify. Award amount: $10,000 max. Project period: 2-year (+ 1-year NCE) Qualifications: Translational research, external funding strategy, the Core does not need to be from the faculty’s home institution Schedule for award: RFA: March/August  Applications Due: May/October  Awards Announced: July/December

6. ACCELERATING CLINICAL AND TRANSLATIONAL RESEARCH www.indianactsi.org Research Inventions and Scientific Commercialization (RISC) Summary: Pilot program to support, foster and encourage cutting edge scientific potential breakthroughs and technology development that will serve as the foundation for new business enterprises and / or promote the advancement of translational research or health related objectives. Award amount: $25,000 max. Project period: 1-year Qualifications: Open to basic and clinical translationsl researchers indentified by the IU Emerging Technologies Center (IUETC) Schedule for award: Rolling application process, no set deadline.

7. ACCELERATING CLINICAL AND TRANSLATIONAL RESEARCH www.indianactsi.org Midwest Strategic Pharma-Academic Research Consortium Research Awards Program (SPARC) Summary: This award is to foster collaborations between academics and pharmas in translational research projects in the area of human Autoimmune Diseases. Award amount: TBA Project period: 2-year Qualifications: Projects must have participation by two (or more) principal investigators representing at least two SPARC partner institutions Schedule for award: TBD

8. ACCELERATING CLINICAL AND TRANSLATIONAL RESEARCH www.indianactsi.org Indiana Clinical Research Center at Purdue Wayne Campbell, PhD, Director campbellw@purdue.edu (765)- 494-8236 campbellw@purdue.edu Clinical Services Blood, Urine, & Muscle Sampling Stable Isotope Infusions Ingestive Behavior & Sensory Evaluation Exercise Training & Physical Fitness Assessment Body Composition And Imaging Services Bone/Soft Tissue (DXA) Whole Body Volume (plethysmography) Whole Body Water (isotope dilution) Bone Geometry (pQCT) Micro Computed Tomography Body Tissues (MRI, MRS, fMRI) Bio-Nutrition Services Menu Development Dietary Counseling Meal Preparation & Service Computerized Nutritional Analysis Dietary Homogenate Prep. & Analysis Dietary and Metabolic Balance Protocols

9. ACCELERATING CLINICAL AND TRANSLATIONAL RESEARCH www.indianactsi.org CHEP Community Based Pilot Projects Summary: Collaborative, community-based research projects: Program evaluation, feasibility or preliminary data for extramural grant submissions. Applicants are encouraged to identify, or further develop, collaborative relationships to be strengthened. Award amount: $15,000-$30,000 per project. $100,000 total available Project period: 1-year Qualifications: MUST be both an academic partner and an community partner on the project. Both partners must currently be working in an Indiana-based institution / organization. Schedule: RFA – April  Due May 16  Awards August 8 th Website: https://www.indianactsi.org/grantinfo/grant/150https://www.indianactsi.org/grantinfo/grant/150

10. ACCELERATING CLINICAL AND TRANSLATIONAL RESEARCH www.indianactsi.org Biomedical Engineering and Bionanotechnology Advise and facilitate the invention, innovation, and testing of medical devices (from nano to macro) through the technology development process. Medical Device Design, Prototyping, and Evaluation –Extensive facilities for materials and electronic fabrication; Experience in implantable electronic, optical, mechanical, acoustical sensors; Dedicated experimental design and evaluation protocol development Nanotechnology Approaches and Therapeutics Development –Nanomaterial core construction and nanometrology measurements; Targeting and therapeutic molecule development; In vitro and in vivo testing of cell-nanomedical system interactions Veterinary Clinical Trials –Trials utilize spontaneous, naturally-occurring disease models; Studies evaluate devices, drugs, nutritional programs; Pathologies range from cancer to orthopedic Preclinical Studies Planning, Coordination and Implementation –Expertise in a wide variety of animal models and procedures; Pre-study planning and new protocol development; Extensive training and study capabilities; Complete after care in recovery studies Histology and Phenotyping –Extensive history with implantable device evaluation; Both soft and hard tissue capabilities; Experienced with device, drug and toxicologic, and infectious disease pathologies